Demonstrated efficacy for patients at risk
In real world and clinical environments, the DyeVert™ PLUS EZ system has been shown to improve clinical outcomes by reducing AKI rates in high-risk patients.
Real-world results:
55% AKI reduction
Cath lab quality improvement programs to reduce AKI demonstrated a 55% mean relative AKI reduction with the DyeVert System.1-4
Comparative results:
51% AKI reduction
Studies comparing AKI rates in patients treated with and without the DyeVert System demonstrated a 51% mean relative AKI reduction in patients treated with DyeVert.5-8
By minimizing excess reflux, the DyeVert System reduces contrast delivered to patients without compromising image quality.
Reduced contrast volume leads to decreased reflux
Unnecessary contrast volume leads to excess reflux
The DyeVert System uses Bluetooth technology to accurately show how much contrast is delivered to a patient during a procedure.
Cumulative contrast volume delivered to patient
per injection contrast volume to patient
Contrast level remaining until threshold max is reached
Physician-specified threshold volume max
Percent contrast saved per injection